Developer docs
API playgroundTry for free, no card

Search company profiles

Medcaptain

Full company profile

uuid0003z51

Namestring
Medcaptain
Legal namestring
Medcaptain Medical Technology Co., Ltd.
Websiteurl
medcaptain.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Medcaptain Medical Technology Co., Ltd. is a privately held Chinese medical technology company founded in 2011 and headquartered in Shenzhen, Guangdong. The company is described as a "high-end infusion instruments and consumables integrated solution provider," operating across three horizontal business units — Life Support, Minimally Invasive Intervention, and In-vitro Diagnostics — that collectively address critical care, surgical intervention, and clinical laboratory testing use cases for healthcare providers.

The product portfolio includes medical life support systems and equipment for critical and emergency care, devices and consumables for minimally invasive surgical and interventional procedures, and in-vitro diagnostic products for analyzing biological samples. The three-BU architecture allows Medcaptain to serve multiple clinical verticals from a single integrated platform, with each unit contributing distinct device and consumable lines. The company maintains an active digital presence through its corporate website (medcaptain.com), YouTube, LinkedIn, and Facebook, alongside an operational careers page indicating ongoing organizational activity.

Business model details — including pricing, distribution channels, customer segmentation, and revenue mechanics — are not disclosed in available sources. The company has raised approximately $1.9M across two early-stage rounds (2016 from Shenzhen Capital Group and Shenzhen Guozhong Venture Capital; 2017 from Hillhouse Investment), suggesting it has grown primarily through self-funded operations rather than repeated external capital raises. With 1,001–5,000 employees and 13+ years of continuous operation, Medcaptain is a meaningful mid-sized player in China's domestic medical device market, though specific revenue, profitability, and customer metrics remain undisclosed.

Short descriptiontext

Medcaptain Medical Technology Co., Ltd. is a privately held Chinese medical device company founded in 2011 in Shenzhen, operating across three business units — Life Support, Minimally Invasive Intervention, and In-vitro Diagnostics — to provide high-end infusion instruments, devices, and consumables to healthcare providers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersShenzhen, China
HQ citystring
Shenzhen
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
medical infusion devices, life support equipment, minimally invasive intervention, in-vitro diagnostics, medical consumables
NAICS code2 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Medical Laboratories8071
Product category
Medical Devices
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Medcaptain is a Chinese medical technology company that designs, manufactures, and supplies high-end infusion instruments and consumables, along with medical technology solutions organized into three business units: Life Support, Minimally Invasive Intervention, and In-vitro Diagnostics. The company's products serve critical care, emergency, surgical, and clinical laboratory applications for healthcare providers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Medcaptain is a medical technology company offering a portfolio of healthcare products organized across three main business units: Life Support, Minimally Invasive Intervention, and In-vitro Diagnostics. The company focuses on medical devices and diagnostic solutions aimed at preserving life and health. The portfolio architecture consists of these three interconnected product categories serving different aspects of medical care delivery.

Product and service4 records
1Life Support
CategoryLife Support Medical Equipment
Description

Medical life support systems and equipment designed for critical care and emergency situations in healthcare settings. These products support vital functions for patients in intensive care, emergency departments, and other critical care environments.

2Minimally Invasive Intervention
CategoryMinimally Invasive Surgical Devices
Description

Medical devices and solutions for minimally invasive surgical and interventional procedures. These products enable healthcare providers to perform surgical interventions with reduced patient trauma, shorter recovery times, and lower complication rates compared to traditional open surgery.

3In-vitro Diagnostics
CategoryIn-vitro Diagnostic Equipment
Description

Diagnostic testing products and solutions for analyzing biological samples outside the body in clinical laboratory settings. These products support disease diagnosis, health monitoring, and clinical decision-making through laboratory-based testing.

4High-end Infusion Instruments and Consumables
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global leader in infusion therapy systems and consumables, the exact product category where Medcaptain is positioned as a 'high-end' integrated provider. B. Braun is the international benchmark for the addressable market.

2MicroPort Scientific
TypeDirect peer
Description

Shanghai-based diversified medical device company with presence in minimally invasive intervention, orthopedics, and patient monitoring. Closely comparable to Medcaptain's Minimally Invasive Intervention and Life Support business units.

3Nipro
TypeDirect peer
Description

Japanese medical device manufacturer specializing in renal, infusion, and injection-related products. Comparable to Medcaptain's high-end infusion and consumables positioning across the broader Asian medtech landscape.

TypeDirect peer
Description

U.S.-based specialist in medical infusion systems, IV consumables, and critical care devices. Comparable to Medcaptain's core infusion and life support offering, with similar focus on high-reliability clinical products.

TypeBroad incumbent
Description

Global medical technology incumbent with extensive infusion, IV consumables, and diagnostics portfolios. Overlaps with Medcaptain in infusion pumps and IVD consumables but serves a much broader product range globally.

TypeDirect peer
Description

Shenzhen-headquartered medical device leader with overlapping product lines in patient monitoring, life support, and in-vitro diagnostics. Mindray is the most direct Chinese competitor and benchmark for Medcaptain's premium domestic positioning.

TypeDirect peer
Description

Beijing-headquartered Chinese medtech company with broad portfolio across interventional cardiology, IVD, and critical care equipment. Directly comparable Chinese competitor to Medcaptain in multiple segments.

TypeDirect peer
Description

China-based IVD specialist and one of the largest domestic diagnostic device manufacturers. Directly comparable to Medcaptain's In-vitro Diagnostics business unit as a Chinese IVD peer.

TypeDirect peer
Description

Japanese global medical device manufacturer with strong presence in infusion systems, blood transfusion, and interventional devices. Closely aligned with Medcaptain's life support, infusion, and minimally invasive intervention portfolio.

TypeDirect peer
Description

Major global supplier of infusion pumps, IV consumables, and clinical nutrition products. Directly comparable to Medcaptain's infusion and life support portfolio in product scope and hospital customer base.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds12 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors25 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medcaptain

Medical Devicesmedcaptain.com

Medcaptain Medical Technology Co., Ltd. is a privately held Chinese medical device company founded in 2011 in Shenzhen, operating across three business units — Life Support, Minimally Invasive Intervention, and In-vitro Diagnostics — to provide high-end infusion instruments, devices, and consumables to healthcare providers.

What Medcaptain does

Medcaptain Medical Technology Co., Ltd. is a privately held Chinese medical technology company founded in 2011 and headquartered in Shenzhen, Guangdong. The company is described as a "high-end infusion instruments and consumables integrated solution provider," operating across three horizontal business units — Life Support, Minimally Invasive Intervention, and In-vitro Diagnostics — that collectively address critical care, surgical intervention, and clinical laboratory testing use cases for healthcare providers.

The product portfolio includes medical life support systems and equipment for critical and emergency care, devices and consumables for minimally invasive surgical and interventional procedures, and in-vitro diagnostic products for analyzing biological samples. The three-BU architecture allows Medcaptain to serve multiple clinical verticals from a single integrated platform, with each unit contributing distinct device and consumable lines. The company maintains an active digital presence through its corporate website (medcaptain.com), YouTube, LinkedIn, and Facebook, alongside an operational careers page indicating ongoing organizational activity.

Business model details — including pricing, distribution channels, customer segmentation, and revenue mechanics — are not disclosed in available sources. The company has raised approximately $1.9M across two early-stage rounds (2016 from Shenzhen Capital Group and Shenzhen Guozhong Venture Capital; 2017 from Hillhouse Investment), suggesting it has grown primarily through self-funded operations rather than repeated external capital raises. With 1,001–5,000 employees and 13+ years of continuous operation, Medcaptain is a meaningful mid-sized player in China's domestic medical device market, though specific revenue, profitability, and customer metrics remain undisclosed.

Medcaptain firmographics

Firmographics
Name
Medcaptain
Legal name
Medcaptain Medical Technology Co., Ltd.
Website
https://medcaptain.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Short description
Medcaptain Medical Technology Co., Ltd. is a privately held Chinese medical device company founded in 2011 in Shenzhen, operating across three business units — Life Support, Minimally Invasive Intervention, and In-vitro Diagnostics — to provide high-end infusion instruments, devices, and consumables to healthcare providers.
Ownership category
akta.pro rank

Where Medcaptain is headquartered

Location

Headquarters

HQ city
Shenzhen
HQ country
China
HQ region
Asia

Markets served

Medcaptain business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Marketing channels4 records

Medcaptain product offering

Product offering

Core offering

Medcaptain is a Chinese medical technology company that designs, manufactures, and supplies high-end infusion instruments and consumables, along with medical technology solutions organized into three business units: Life Support, Minimally Invasive Intervention, and In-vitro Diagnostics. The company's products serve critical care, emergency, surgical, and clinical laboratory applications for healthcare providers.

Product overview

Medcaptain is a medical technology company offering a portfolio of healthcare products organized across three main business units: Life Support, Minimally Invasive Intervention, and In-vitro Diagnostics. The company focuses on medical devices and diagnostic solutions aimed at preserving life and health. The portfolio architecture consists of these three interconnected product categories serving different aspects of medical care delivery.

Differentiator

Problem solved

Functional benefit

Products and services

  • Life Support Medical life support systems and equipment designed for critical care and emergency situations in healthcare settings. These products support vital functions for patients in intensive care, emergency departments, and other critical care environments.
  • Minimally Invasive Intervention Medical devices and solutions for minimally invasive surgical and interventional procedures. These products enable healthcare providers to perform surgical interventions with reduced patient trauma, shorter recovery times, and lower complication rates compared to traditional open surgery.
  • In-vitro Diagnostics Diagnostic testing products and solutions for analyzing biological samples outside the body in clinical laboratory settings. These products support disease diagnosis, health monitoring, and clinical decision-making through laboratory-based testing.
  • High-end Infusion Instruments and Consumables

Companies that use Medcaptain

Customer profile

Segments3 records

Ideal customer profiles1 record

Medcaptain technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Medcaptain partnerships and signals

Strategic signal

Recent moves4 records

Expansion highlights4 records

Medcaptain competitors and assessment

Company assessment

Direct peers

  • B. Braun Melsungen: Global leader in infusion therapy systems and consumables, the exact product category where Medcaptain is positioned as a 'high-end' integrated provider. B. Braun is the international benchmark for the addressable market.
  • MicroPort Scientific: Shanghai-based diversified medical device company with presence in minimally invasive intervention, orthopedics, and patient monitoring. Closely comparable to Medcaptain's Minimally Invasive Intervention and Life Support business units.
  • Nipro: Japanese medical device manufacturer specializing in renal, infusion, and injection-related products. Comparable to Medcaptain's high-end infusion and consumables positioning across the broader Asian medtech landscape.
  • ICU Medical: U.S.-based specialist in medical infusion systems, IV consumables, and critical care devices. Comparable to Medcaptain's core infusion and life support offering, with similar focus on high-reliability clinical products.
  • Mindray Medical: Shenzhen-headquartered medical device leader with overlapping product lines in patient monitoring, life support, and in-vitro diagnostics. Mindray is the most direct Chinese competitor and benchmark for Medcaptain's premium domestic positioning.
  • Lepu Medical: Beijing-headquartered Chinese medtech company with broad portfolio across interventional cardiology, IVD, and critical care equipment. Directly comparable Chinese competitor to Medcaptain in multiple segments.
  • Sinocare: China-based IVD specialist and one of the largest domestic diagnostic device manufacturers. Directly comparable to Medcaptain's In-vitro Diagnostics business unit as a Chinese IVD peer.
  • Terumo: Japanese global medical device manufacturer with strong presence in infusion systems, blood transfusion, and interventional devices. Closely aligned with Medcaptain's life support, infusion, and minimally invasive intervention portfolio.
  • Fresenius Kabi: Major global supplier of infusion pumps, IV consumables, and clinical nutrition products. Directly comparable to Medcaptain's infusion and life support portfolio in product scope and hospital customer base.

Broad incumbents

  • Becton Dickinson (BD): Global medical technology incumbent with extensive infusion, IV consumables, and diagnostics portfolios. Overlaps with Medcaptain in infusion pumps and IVD consumables but serves a much broader product range globally.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Medcaptain social profiles

Digital presence

Medcaptain financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medcaptain leadership team

Management profile

Number of profiles

Profiles2 records

Medcaptain funding detail

Funding detail

Funding overview

Funding rounds12 records

Investors25 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medcaptain M&A and investment

M&A and investment

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medcaptain

What does Medcaptain do?

Medcaptain is a Chinese medical technology company that designs, manufactures, and supplies high-end infusion instruments and consumables, along with medical technology solutions organized into three business units: Life Support, Minimally Invasive Intervention, and In-vitro Diagnostics. The company's products serve critical care, emergency, surgical, and clinical laboratory applications for healthcare providers.

Is Medcaptain a public or private company?

Medcaptain is a private company. It is classified as venture growth investor backed and is currently operating.

When was Medcaptain founded?

Medcaptain was founded in 2011. It employs 101 to 250 people.

Where is Medcaptain based?

Medcaptain is headquartered in Shenzhen, China, in the Asia region.

Who are Medcaptain's main competitors?

Direct peers on record are B. Braun Melsungen, MicroPort Scientific, Nipro, ICU Medical, Mindray Medical, Lepu Medical, Sinocare, Terumo and Fresenius Kabi. Becton Dickinson (BD) is listed as a broad incumbent.

Does Medcaptain have an API?

No public API is recorded for Medcaptain.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AInvestMedcaptain says trading expected to begin September 7Medcaptain Medical Technology Co. Ltd. said its shares are expected to begin trading on the Hong Kong Stock Exchange on September 7, 2026, after filing an IPO application on September 11, 2025 with Morgan Stanley and Huatai International as joint sponsors. Revenues rose from 917 million yuan in 2022 to nearly 1.4 billion yuan in 2024, and the company posted its first half-year net profit in 2025.AInvestMedcaptain offers 38.9M shares in Hong Kong IPOMedcaptain Medical Technology Co., Ltd. announced plans to offer 38.9 million shares through an initial public offering on the Hong Kong stock exchange, described as a step toward expanding its capital base and market visibility. Pricing and valuation were not disclosed, and the filing showed strengthening financial flexibility. Specific financial performance metrics or operational updates were not publicly shared.AInvestMedcaptain Medical HK IPO could raise up to $100M: IFRNo content on the titled subject is present; the body is a paywall stub with only a headline and subscription prompts.BenzingaMedcaptain Pursues Hong Kong IPO Following Newfound ProfitabilityMedcaptain Medical Technology Co. Ltd., a Chinese medical device maker, filed an IPO application with the Hong Kong Stock Exchange on September 11, with Morgan Stanley and Huatai International as joint sponsors. The company achieved its first profit in H1 2025, posting a net profit of 40.97 million yuan versus a loss of 58.03 million yuan in the same period of 2024, as revenue grew 15.31% to 787 million yuan. Backed by Hillhouse Capital (20.79%) and Shenzhen Capital Group (8.54%), Medcaptain—which holds China's top position in infusion workstations and serves over 140 countries—commands a valuation of 8.25 billion yuan following its last financing round in 2023.